Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 4Colorectal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Colonic Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Tongue Neoplasms 1Spondylitis, Ankylosing 1Recurrence 1Rectal Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Liver Neoplasms 1Hand-Foot Syndrome 1Endometrial Neoplasms 1Colon Cancer Stage 1Bile Duct Neoplasms 1

Interventions

Cyclophosphamide 17fludarabine 13Dexamethasone 12Cisplatin 11Rituximab 10Gemcitabine 9Paclitaxel 7Lenalidomide 7Decitabine 7Cytarabine 7Bendamustine Hydrochloride 7fludarabine phosphate 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Etoposide 6Carboplatin 6Bortezomib 6Radiotherapy 5Injections 5Azacitidine 5camrelizumab 4apatinib 4Valproic Acid 4Thalidomide 4Procarbazine 4Oxaliplatin 4Drug Therapy 4Antilymphocyte Serum 4tislelizumab 3pomalidomide 3liposomal doxorubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Recurrence × Celecoxib × Clear all
NCT02739204 2016-04-15

Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell Carcinoma

China Medical University Hospital

Phase 2 Unknown
270 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡